Introduction
Depo-Provera has been a widely used birth control injection for decades because it’s convenient and effective. But recent medical studies have raised an important health concern: long-term use of Depo-Provera may increase the risk of developing meningiomas — a type of brain tumor that, while often benign, can cause serious neurological symptoms.
What Is a Meningioma?
A meningioma is a growth that develops from the meninges — the protective layers surrounding the brain and spinal cord. Most are not cancerous, but because of their location in the skull, they can press on brain tissue and lead to symptoms like:
- Chronic headaches
- Vision changes
- Balance or coordination problems
- Seizures
- Cognitive or memory issues
Symptoms often mirror common neurological complaints, which can delay diagnosis if not investigated promptly.
The Link to Depo-Provera
Depo-Provera works by delivering the synthetic hormone medroxyprogesterone acetate (MPA) into the body. Recent studies — including a large French population analysis — found that women who used Depo-Provera for one year or more had an up to 5.6-fold increase in meningioma diagnosis requiring surgery compared to non-users.
In late 2025, the U.S. Food and Drug Administration (FDA) added a warning about the potential for brain tumors to Depo-Provera labels, reflecting this emerging evidence.
What This Means for You
Whether you’re considering Depo-Provera or have used it before, here are some important points:
✔️ Risk increases with longer use: Extended use over multiple years appears to raise the likelihood of developing a meningioma.
✔️ Symptoms deserve attention: Persistent neurological symptoms should always be evaluated by a healthcare provider.
✔️ Talk to your clinician: If you have concerns — especially after long-term use — ask about alternative contraceptives and whether imaging (like MRI) may be appropriate.
Real Stories, Real Impact
Many women who developed meningiomas after using Depo-Provera describe difficult diagnostic journeys and life-altering impacts due to delayed awareness of this risk. While not all users will develop a tumor, awareness empowers early action and better health decisions.
Conclusion
This connection between Depo-Provera and brain tumors is still being researched, but the evidence today supports a real increased risk — especially with prolonged use. Speak openly with your healthcare provider about your history and make an informed choice that’s right for your body.
About the Author
